SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
GENZYME - THE KING OF THE BIOTECHS
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
410 21 0 GENZ
Emcee:  ajcmr Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
110 wsnob, You can get a copy of the second periodic report of the Carticel ServiceVector1-2/23/1997
109 I would be happy to express my views on both GENZL and GZTC. However, you havewsnob-2/23/1997
108 I'm fully recovered now,thanks. I am also an investor in transgenics and aVector1-2/22/1997
107 Vector1, Sorry to give you a momentary heart attack. I completely agree with wsnob-2/22/1997
106 Thanks Antal, As an investor in the company, it's nice to hear such commenalice simmons-2/21/1997
105 Dear Viktor: You have picked a winner. I have had the chance to work with a prajcmr-2/21/1997
104 I was stunned for a few seconds when I read your prior post--I didn't realiVector1-2/21/1997
103 I completely agree with you. I believe they are developing Sepracoat as well, wsnob-2/20/1997
102 DO NOT GET SUCKED INTO THIS DOG! This company is basically developing diagnostwsnob-2/20/1997
101 Genzyme was recommended today on CNBC but could not advance with this selloff tMichael H. Dragon-2/20/1997
100 I'll try and track down the report. Swartz at First Boston who along with DVector1-2/12/1997
99 As far as what the analysts say i got a report from Smith Barney's lenstra Scott Ozer-2/12/1997
98 That is a great insight. ThermoElectron in Waltham, MA has used this techniqueHarold Engstrom-2/12/1997
97 Harold, I wonder if Genzyme's unusual capital structure negatively effects Vector1-2/12/1997
96 Genzyme Transgenics Announces Three Milestones in Transgenic Production of MonoStephen Blumenthal-2/7/1997
95 To all--Genz fundamentals--- I got the Genz investor package some days ago andSpekulatius-2/5/1997
94 NEWS!!! FIVE Cancer Dectection Products (OTC/BB: AMDD) ask = .47 Read it foStreet Walker-2/3/1997
93 I agree, Vector. Genzyme is the only company I feel comfortable with right nowHarold Engstrom-2/3/1997
92 Genzyme Creates Molecular Oncology Division with Acquisition of PharmaGenics Harold Engstrom-2/3/1997
91 GENZ is clearly the best buy in biotecs from a risk reward standpoint. I believVector1-2/3/1997
90 Well,my Aug was a bad pick,but we should compromise between Feb with the two( fChuca Marsh-1/31/1997
89 I didn't realize they stated earnings wouldn't be due out till March; sMichael H. Dragon-1/31/1997
88 Michael: What is the actual PE (unadjusted for aq. charge) at this moment? Secajcmr-1/31/1997
87 I think this stock should do great this year,premiums for calls are quite expenMichael H. Dragon-1/31/1997
86 Mike ,hi , What do you think of Calls on Genz, I think they go out to Aug, And Chuca Marsh-1/31/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News